During pregnancy … does paracetamol increase the risk of autism?

A recent study reported that there are indications of a possible relationship between the use of paracetamol (acetaminophen) during pregnancy and an increase in the risk of children with autism spectrum disorders (ASD). This comes within the framework of a federal review by health officials in the United States to understand the reasons for high autism among children, amid increased anxiety about the common drugs that are taken during pregnancy.

Paracetamol is known for its relief and hypogine effect, and it is sold under commercial names such as “Panadol” and “Tilanol”. It is widely used among pregnant women, where it is estimated that about half of pregnant women in the UK and 65% in the United States resort to this medicine in various pregnancy periods. Health bodies consider it a safe option, provided that they adhere to low doses and for short periods, but recent studies have linked its use during pregnancy to an increase in the possibility of autism or hyperactivity disorder and attention lack (ADHD).

It is expected that US President Donald Trump will officially adopt this link, as part of an initiative led by current Minister of Health Robert F. Kennedy Junior, known for his controversial stances towards some medications and vaccines. Recent recommendations call for women to take Paracetamol only under direct medical supervision, taking into account the potential risks of brain growth and the cognitive capabilities of the fetus.

Studies have shown that the interaction between genetic and environmental factors, such as exposure to chemicals or medications during pregnancy, may contribute to neurological changes that affect the development of the brain, which explains the fears of paracetamol to nervous growth disorders. Although the results are still under search, doctors urge caution and follow accurate directions when using any residence during pregnancy.

(Erm News)